GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human ppargamma ligand binding domain in complex with hydroxy pioglitazone (M-IV)

Analyse Crystal structure of human ppargamma ligand binding domain in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6DHA
Type
protein
Length
518 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma
UniProt
P37231
Ligands
GFV, KNA
Pockets
7 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 68% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein25569% helix, 5% strandP37231
BPeroxisome proliferator-activated receptor gammaprotein26366% helix, 5% strandP37231

Ligands and binding sites

  • GFV · Hydroxy Pioglitazone (M-IV) · ligand · 2 copies · chains A, B
  • KNA · nonanoic acid · ligand · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13660.810.9044GFV
24400.750.8446GFV, KNA
35470.670.7759empty
41470.580.8322empty
52220.560.7820empty

Interfaces

1 interface between chains.

  • A–B · 870 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 6DHA · Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Hydroxy… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.